Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > SVA's 1st normal trading day in over a week.

<< Previous

Bullboard Posts

Next >>

Comment by MedStocks2on Jan 24, 2021 7:29pm

320 Views

Post# 32372092

RE:SVA's 1st normal trading day in over a week.

remember there were a bunch of warrants that were extended by three months that were originally set to expire in November. There have probably been a fair number of traders in and out this month but probably some warrant holders taking money off the table and exercising warrants. If that is indeed the case. It is unlikely we will see another financing anytime soon. We will probably be a bit range bound until more news is out or warrants are expired or exercised.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments